1-9 of 9
Jingli Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5567: hYP218 CAR-T cells targeting a membrane-proximal epitope of mesothelin are highly effective against mesothelin expressing cancers

Sakshi Tomar, Jingli Zhang, Nan Li, Ira Pastan, Mitchell Ho, Raffit Hassan
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5567.
DOI: https://doi.org/10.1158/1538-7445.AM2022-5567
Published: 15 June 2022
View article
Journal Articles

Abstract 667: Genomic and transcriptomic profiling of malignant mesothelioma patients identifies gene signatures predictive of survival and response to immuno and chemotherapy

Nishanth Ulhas Nair, Qun Jiang, Jun S. Wei, Vikram A. Misra, Betsy Morrow, Leandro C. Hermida, Joo Sang Lee, Idrees Mian, Jingli Zhang, Manjistha Sengupta, Javed Khan, Eytan Ruppin, Raffit Hassan
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 667.
DOI: https://doi.org/10.1158/1538-7445.AM2021-667
Published: 01 July 2021
View article
Journal Articles

Abstract 1382: Megakaryocyte potentiating factor as a predictive biomarker for therapies against malignant mesothelioma

Liang Cao, Yunkai Yu, Anish. Thomas, Jingli Zhang, Masanori Onda, Paul Meltzer, Raffit Hassan, Ira Pastan
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1382.
DOI: https://doi.org/10.1158/1538-7445.AM2019-1382
Published: 01 July 2019
View article
Journal Articles

Abstract 3813: MPF as a monitoring biomarker for a mesothelin-targeted therapy against malignant mesothelioma and other cancer

Yunkai Yu, Raffit Hassan, Jingli Zhang, Masanori Onda, Ira Pastan, Liang Cao
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3813.
DOI: https://doi.org/10.1158/1538-7445.AM2017-3813
Published: 01 July 2017
View article
Journal Articles

Abstract 3103: The reduced immunogenicity anti-mesothelin immunotoxin RG7787 in combination with nab-paclitaxel has significant anti-tumor efficacy against primary mesothelioma cell lines and patient derived mesothelioma tumor xenografts

Jingli Zhang, Qun Jiang, Christine Alewine, Swati Khanna, Betsy Morrow, Anish Thomas, Ira Pastan, Raffit Hassan
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3103.
DOI: https://doi.org/10.1158/1538-7445.AM2016-3103
Published: 15 July 2016
View article
Journal Articles

Abstract 3247: Granulocytic MDSCs (CD11b+CD15+CD14-HLADR-) in peripheral blood of mesothelioma patients are elevated and suppress T cell proliferation and function via reactive oxygen species

Swati Khanna, Francis Mussai, Anish Thomas, Gary Middleton, Constance Yuan, Betsy Morrow, Jingli Zhang, Ira Pastan, Maryalice Stetler-Stevenson, Raffit Hassan
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3247.
DOI: https://doi.org/10.1158/1538-7445.AM2016-3247
Published: 15 July 2016
View article
Journal Articles

Cytotoxic Activity of Immunotoxin SS1P Is Modulated by TACE-Dependent Mesothelin Shedding

Yujian Zhang, Oleg Chertov, Jingli Zhang, Raffit Hassan, Ira Pastan
Journal: Cancer Research
Cancer Res (2011) 71 (17): 5915–5922.
DOI: https://doi.org/10.1158/0008-5472.CAN-11-0466
Published: 30 August 2011
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 646: Anti-tumor efficacy of IMC-A12, a fully human anti-insulin like growth factor 1 receptor (IGF-1R) antibody, against malignant mesothelioma (MM)

Neetu Kalra, Jingli Zhang, Yunkai Yu, Mitchell Ho, Liang Cao, Raffit Hassan
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 646.
DOI: https://doi.org/10.1158/1538-7445.AM2011-646
Published: 15 April 2011
View article
Journal Articles

Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients

Mitchell Ho, Raffit Hassan, Jingli Zhang, Qing-Cheng Wang, Masanori Onda, Tapan Bera, Ira Pastan
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 360.
Published: 01 May 2005
View article